SAMJIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 005500 for the last quarter is 70.75 B KRW, and it's 2.49% lower compared to the previous quarter. The net income of Q2 24 is 24.79 B KRW.